24/7 Market News Snapshot 26 June, 2025 – INmune Bio Inc. Common stock (NASDAQ:INMB)

June 26, 2025

DENVER, Colo., 26 June, 2025 (www.247marketnews.com) – (NASDAQ:INMB) are discussed in this article.
INmune Bio Inc. (INMB) is experiencing significant bullish momentum, evidenced by an 18.15% increase today, with shares climbing from an opening price of $7.40 to a current trading price of $8.71. This surge reflects growing investor confidence, characterized by a trading volume of 2.63 million shares. The stock’s impressive ascent may be attributed to favorable market sentiment and solid financial performance, prompting traders to monitor key resistance levels above $8.70 and support around $7.40, which are crucial for assessing the sustainability of this demand. Utilizing technical indicators, such as moving averages, could further assist investors in making informed decisions regarding future price movements and associated risk management strategies.

Furthermore, INmune Bio has announced an upcoming conference call set for June 30, 2025, at 8:00 AM EDT. This conference will highlight pivotal top-line results from the Phase 2 MINDFuL trial, which focuses on early Alzheimer’s Disease. The MINDFuL trial is a landmark study examining the efficacy of XPro™, a next-generation tumor necrosis factor (TNF) inhibitor, in patients with mild cognitive impairment and Alzheimer’s Disease. By targeting underlying neuroinflammation, a key factor in the progression of neurological disorders, XPro™ represents a novel approach to treatment.

Participants interested in the call are encouraged to join at least ten minutes before the start or utilize the provided webcast link. A transcript will be available approximately 24 hours after the conclusion of the call, alongside a replay option accessible until July 30, 2025. As INmune Bio Inc. continues to innovate in addressing chronic inflammation and cancer with its cutting-edge product platforms, it aims to deliver transformative therapies to those impacted by serious medical conditions, including Alzheimer’s Disease.

Related news for (INMB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.